IL109053A - Suspended release preparation containing tylosin and an anticoagulant in an oil carrier and a process for preparing such a veterinary preparation - Google Patents

Suspended release preparation containing tylosin and an anticoagulant in an oil carrier and a process for preparing such a veterinary preparation

Info

Publication number
IL109053A
IL109053A IL10905394A IL10905394A IL109053A IL 109053 A IL109053 A IL 109053A IL 10905394 A IL10905394 A IL 10905394A IL 10905394 A IL10905394 A IL 10905394A IL 109053 A IL109053 A IL 109053A
Authority
IL
Israel
Prior art keywords
tylosin
sustained release
release composition
composition according
amount
Prior art date
Application number
IL10905394A
Other languages
English (en)
Hebrew (he)
Other versions
IL109053A0 (en
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of IL109053A0 publication Critical patent/IL109053A0/xx
Publication of IL109053A publication Critical patent/IL109053A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL10905394A 1993-03-24 1994-03-21 Suspended release preparation containing tylosin and an anticoagulant in an oil carrier and a process for preparing such a veterinary preparation IL109053A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939306106A GB9306106D0 (en) 1993-03-24 1993-03-24 Sustained release veterinary composition

Publications (2)

Publication Number Publication Date
IL109053A0 IL109053A0 (en) 1994-06-24
IL109053A true IL109053A (en) 1999-09-22

Family

ID=10732660

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10905394A IL109053A (en) 1993-03-24 1994-03-21 Suspended release preparation containing tylosin and an anticoagulant in an oil carrier and a process for preparing such a veterinary preparation

Country Status (23)

Country Link
EP (1) EP0689444B1 (bg)
JP (1) JPH08508032A (bg)
KR (1) KR100283369B1 (bg)
CN (1) CN1096268C (bg)
AT (1) ATE181834T1 (bg)
AU (1) AU669435B2 (bg)
BG (1) BG62352B1 (bg)
BR (1) BR9406202A (bg)
CA (1) CA2158662C (bg)
DE (1) DE69419408T2 (bg)
DK (1) DK0689444T3 (bg)
ES (1) ES2135568T3 (bg)
FI (1) FI954447A (bg)
GB (1) GB9306106D0 (bg)
GR (1) GR3031293T3 (bg)
HU (1) HUT73424A (bg)
IL (1) IL109053A (bg)
NO (1) NO953647L (bg)
NZ (1) NZ262756A (bg)
PE (1) PE7595A1 (bg)
PL (1) PL175127B1 (bg)
RO (1) RO114738B1 (bg)
WO (1) WO1994021267A1 (bg)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
MXPA05004219A (es) * 2002-10-25 2005-06-08 Akzo Nobel Nv Composicion farmaceutica de liberacion prolongada.
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善
CN116407505A (zh) * 2023-03-28 2023-07-11 青岛康地恩动物药业有限公司 一种高生物利用度泰万菌素干混悬剂及制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
PT76448B (en) * 1982-04-05 1986-03-20 Merck Sharp & Dohme Process for preparing stabilization of unstable drugs or food supplements containing antibiotics mainly ephrotomycin
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
ATE66600T1 (de) * 1986-03-10 1991-09-15 American Cyanamid Co Verfahren zur herstellung einer bolusformulierung mit verzoegerter freisetzung.

Also Published As

Publication number Publication date
IL109053A0 (en) 1994-06-24
HU9502700D0 (en) 1995-11-28
PL310804A1 (en) 1996-01-08
CN1096268C (zh) 2002-12-18
FI954447A (fi) 1995-11-15
BR9406202A (pt) 1995-12-12
WO1994021267A1 (en) 1994-09-29
EP0689444B1 (en) 1999-07-07
KR960700732A (ko) 1996-02-24
DE69419408D1 (de) 1999-08-12
GB9306106D0 (en) 1993-05-12
KR100283369B1 (ko) 2001-03-02
NO953647D0 (no) 1995-09-15
ATE181834T1 (de) 1999-07-15
PL175127B1 (pl) 1998-11-30
JPH08508032A (ja) 1996-08-27
CA2158662C (en) 2009-06-30
CN1123525A (zh) 1996-05-29
EP0689444A1 (en) 1996-01-03
FI954447A0 (fi) 1995-09-20
NO953647L (no) 1995-11-22
HUT73424A (en) 1996-07-29
GR3031293T3 (en) 1999-12-31
BG100078A (bg) 1996-07-31
AU669435B2 (en) 1996-06-06
BG62352B1 (bg) 1999-09-30
DE69419408T2 (de) 1999-10-28
PE7595A1 (es) 1995-04-25
DK0689444T3 (da) 1999-11-22
AU6262194A (en) 1994-10-11
NZ262756A (en) 1997-06-24
RO114738B1 (ro) 1999-07-30
ES2135568T3 (es) 1999-11-01
CA2158662A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
JP5990176B2 (ja) タンパク質の安定化に好適な哺乳動物性賦形剤非含有製剤
JP5718313B2 (ja) 哺乳類由来の非生理活性添加剤を含まないタンパク質安定化製剤
CA2139358C (en) Human growth hormone aqueous formulation
CN103272243A (zh) 含有改性的赋形剂的药物组合物
MX2014004792A (es) Metodo de tratamiento o reduccion de efp.
AU2008243150B2 (en) Formulation comprising bioactive agents and methods of using same
EP0809512A1 (en) Pharmaceutical non inorganic saline solutions for endonasal administration of a calcitonin
JPH11222441A (ja) ヒト成長ホルモン含有水性医薬組成物
CA2285052C (en) Improvements in or relating to long-acting antimicrobials
EP0689444B1 (en) Tylosin containing sustained release veterinary compositions
JPH04282322A (ja) 生物活性ペプチド製剤
AU737983B2 (en) An oil composition of dihydropolyprenols
RU2182830C1 (ru) Таблетированная форма рекомбинантного человеческого эритропоэтина
GB2232082A (en) Sustained release amoxycillin preparation
NZ337696A (en) Veterinary compositions containing long-acting antimicrobials and anti-inflammatory agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired